- Home
- CGON
CGON
CG ONCOLOGY INC
as 12-18-2024 4:00pm EST
Stocks
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 2.4B | IPO Year: | 2024 |
| Target Price: | $63.88 | AVG Volume (30 days): | 819.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.77 - $50.23 | Next Earning Date: | 02-02-2025 |
| Revenue: | $684,000 | Revenue Growth: | 258.12% |
| Revenue Growth (this year): | 165.75% | Revenue Growth (next year): | 47.04% |
Stock Insider Trading Activity of CG ONCOLOGY INC (CGON)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| POST LEONARD E | CGON | Director | Dec 16 '24 | Sell | $28.84 | 1,000 | $28,840.00 | 0 |
Latest CG ONCOLOGY INC News
CGON Breaking Stock News: Dive into CGON Ticker-Specific Updates for Smart Investing
MT Newswires
13 hours ago
CG Oncology Insider Sold Shares Worth $19,600,000, According to a Recent SEC Filing
MT Newswires
2 days ago
CG Oncology Closes $238 Million Offering
GlobeNewswire
2 days ago
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
MT Newswires
6 days ago
CG Oncology Prices $204.4 Million Public Offering
GlobeNewswire
6 days ago
CG Oncology Announces Pricing of Public Offering
MT Newswires
7 days ago
CG Oncology Files for Proposed Public Share Offering
GlobeNewswire
7 days ago
CG Oncology Announces Proposed Public Offering
GlobeNewswire
12 days ago
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
Compare CGON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CGON CG ONCOLOGY INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.